Evidence map›Paper›PMID 37853264›Full record

Observational studyClinical oral investigations2023

The effect of conditioning regimen and prescribed medications on hyposalivation in haematopoietic cell transplantation (HCT) patients: an 18-month prospective longitudinal study.

Marjolein S Bulthuis, Lucky L A van Gennip, Renske Z Thomas, Ewald M Bronkhorst, Alexa M G A Laheij, Judith E Raber-Durlacher, Frederik R Rozema, Michael T Brennan, Inger von Bültzingslöwen, Nicole M A Blijlevens and 2 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Clinical oral investigations, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Marjolein S BulthuisDepartment of Dentistry, Radboud University Medical Center, Nijmegen, The Netherlands. Marjolein.Bulthuis@radboudumc.nl.
Lucky L A van GennipDepartment of Dentistry, Radboud University Medical Center, Nijmegen, The Netherlands.
Renske Z ThomasDepartment of Dentistry, Radboud University Medical Center, Nijmegen, The Netherlands.
Ewald M BronkhorstDepartment of Dentistry, Radboud University Medical Center, Nijmegen, The Netherlands.
Alexa M G A LaheijDepartment of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University, Amsterdam, The Netherlands.
Judith E Raber-DurlacherDepartment of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University, Amsterdam, The Netherlands.
Frederik R RozemaDepartment of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University, Amsterdam, The Netherlands.
Michael T BrennanDepartment of Oral Medicine/Oral & Maxillofacial Surgery, Atrium Health Carolinas Medical Center, Charlotte, NC; Department of Otolaryngology/Head & Neck Surgery, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Inger von BültzingslöwenDepartment of Oral Microbiology and Immunology, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Nicole M A BlijlevensDepartment of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Marie-Charlotte D N J M HuysmansDepartment of Dentistry, Radboud University Medical Center, Nijmegen, The Netherlands.
Stephanie J M van LeeuwenDepartment of Dentistry, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud University Medical Center · NLRadboud University Nijmegen · NLAcademic Center for Dentistry Amsterdam · NLUniversity of Amsterdam · NLUniversity of Gothenburg · SEWake Forest University · US

Funding

KWF Kankerbestrijding ACTA 2014-7468
6 · The paper itself

Abstract

objectivesHaematopoietic cell transplantation (HCT) preceded by a conditioning regimen is an established treatment option for (non)malignant haematologic disorders. We aim to describe the development of hyposalivation over time in HCT recipients, and determine risk indicators. MATERIALS AND

methodsA multi-centre prospective longitudinal observational study was conducted. Unstimulated (UWS) and stimulated (SWS) whole saliva was collected before HCT, early post-HCT, and after 3, 6, 12, and 18 months. The effect of type of transplantation (allogeneic vs autologous) and intensity (full vs reduced) of the conditioning regimen on hyposalivation (UWS < 0.2 mL/min; SWS < 0.7 mL/min) was explored.

resultsA total of 125 HCT recipients were included. More than half of the patients had hyposalivation early post-HCT; a quarter still had hyposalivation after 12 months. The conditioning intensity was a risk indicator in the development of hyposalivation of both UWS (OR: 3.9, 95% CI: 1.6-10.6) and SWS (OR: 8.2, 95% CI: 2.9-24.6). After 3 and 12 months, this effect was not statistically significant anymore.

conclusionsHyposalivation affects the majority of patients early post-HCT. The conditioning intensity and the type of transplantation were significant risk indicators in the development of hyposalivation. The number of prescribed medications, total body irradiation as part of the conditioning regimen and oral mucosal graft-versus-host disease did not influence hyposalivation significantly. CLINICAL RELEVANCE: Because of the high prevalence of hyposalivation, HCT recipients will have an increased risk of oral complications. It might be reasonable to plan additional check-ups in the dental practice and consider additional preventive strategies.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationXerostomiaHumansLongitudinal StudiesProspective StudiesHaematopoietic cell transplantationHyposalivationMedicationsSalivary flow rate

Identifiers

PMID37853264
PMCPMC10713764
OpenAlexW4387736471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.